Perrigo Company plc (PRGO)

Last Price: 47.07 (2020-09-18)

Company Description

Perrigo Company provides over-the-counter health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. They also produce generic prescription pharmaceutical topical products such as creams, lotions, gels and nasal sprays. They have three reportable segments, aligned primarily by type of product: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $4.84B
Net Income (Most Recent Fiscal Year) $146.10M
PE Ratio (Current Year Earnings Estimate) 11.84
PE Ratio (Trailing 12 Months) 11.33
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 1.30
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.12
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 6.99
Pre-Tax Margin (Trailing 12 Months) 4.92%
Net Margin (Trailing 12 Months) 4.73%
Return on Equity (Trailing 12 Months) 10.05%
Return on Assets (Trailing 12 Months) 5.06%
Current Ratio (Most Recent Fiscal Quarter) 2.05
Quick Ratio (Most Recent Fiscal Quarter) 1.49
Debt to Common Equity (Most Recent Fiscal Quarter) 0.60
Inventory Turnover (Trailing 12 Months) 3.33
Book Value per Share (Most Recent Fiscal Quarter) $42.64
Earnings per Share (Most Recent Fiscal Quarter) $1.03
Earnings per Share (Most Recent Fiscal Year) $4.03
Diluted Earnings per Share (Trailing 12 Months) $1.74
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Common Shares Outstanding 136.48M
Free Float 136.07M
Market Capitalization $6.60B
Average Volume (Last 20 Days) 0.71M
Beta (Past 60 Months) 1.16
Percentage Held By Insiders (Latest Annual Proxy Report) 0.30%
Percentage Held By Institutions (Latest 13F Reports) 83.52%
Annual Dividend (Based on Last Quarter) $0.90
Dividend Yield (Based on Last Quarter) 1.86%